Aptamer reports decent technical, commercial progress
Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
Stay updated with breaking news from Aptamer Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
Aptamer Group PLC (AIM:APTA) shares climbed 8% to 1.3p after it struck a £0.5 million contract with a biotechnology company developing genetic medicines....
Contract comprises up to £553,000 in development fees for the group
Investors' attention at the end of the week will be on a raft of purchasing managers survey results due out in the U.K., euro area and U.S..
Aptamer Group PLC - York-based biotech firm - Signs material agreement with unnamed biotechnology company, focused on developing genetic medicines. Aptamer will use its platform to discover Optimer...